133
Views
2
CrossRef citations to date
0
Altmetric
Review

Imbalanced Coagulation in the Airway of Type-2 High Asthma with Comorbid Obesity

ORCID Icon, , & ORCID Icon
Pages 967-980 | Published online: 10 Aug 2021

References

  • Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC
  • Lefaudeux D, De Meulder B, Loza MJ, et al. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol. 2017;139(6):1797–1807. doi:10.1016/j.jaci.2016.08.048
  • Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–323. doi:10.1164/rccm.200906-0896OC
  • Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-1
  • Walford HH, Doherty TA. Diagnosis and management of eosinophilic asthma: a US perspective. J Asthma Allergy. 2014;7:53–65.
  • Trivedi M, Denton E. Asthma in children and adults-what are the differences and what can they tell us about asthma? Front Pediatr. 2019;7:256. doi:10.3389/fped.2019.00256
  • Gerday S, et al. Asthmatics with concordant eosinophilic disease classified according to their serum IgE status. Respir Med Res. 2021;79:100797.
  • Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011;127(6):1486–93e2. doi:10.1016/j.jaci.2011.03.036
  • Abdo M, Trinkmann F, Kirsten A-M, et al. Small airway dysfunction links asthma severity with physical activity and symptom control. J Allergy Clin Immunol Pract. 2021. doi:10.1016/j.jaip.2021.04.035
  • Wang M, Gao P, Wu X, et al. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res. 2016;17(1):153. doi:10.1186/s12931-016-0462-0
  • Hinks TS, Levine SJ, Brusselle GG. Treatment options in type-2 low asthma. Eur Respir J. 2020;57:1.
  • Chaudhry R, Usama SM, Babiker HM. Physiology, Coagulation Pathways. Treasure Island (FL): StatPearls; 2020.
  • Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134(5):1087–1097.
  • Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86(8):2839–2843. doi:10.1073/pnas.86.8.2839
  • Fleck RA, Rao LVM, Rapaport SI, et al. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59(2):421–437. doi:10.1016/0049-3848(90)90148-6
  • Smith SA, Travers RJ, Morrissey JH. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015;50(4):326–336. doi:10.3109/10409238.2015.1050550
  • Bazan-Socha S, Mastalerz L, Cybulska A, et al. Asthma is associated with enhanced thrombin formation and impaired fibrinolysis. Clin Exp Allergy. 2016;46(7):932–944. doi:10.1111/cea.12734
  • Samuels J, Lawson PJ, Morton AP, et al. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery. Surg Obes Relat Dis. 2019;15(7):1153–1159. doi:10.1016/j.soard.2019.03.048
  • Boulet L-P, Turcotte H, Martin J, et al. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Respir Med. 2012;106(5):651–660. doi:10.1016/j.rmed.2011.12.012
  • Chaaban TA. Bariatric surgery: a potential cure for asthma? Eur Respir Rev. 2019;28(152):190003. doi:10.1183/16000617.0003-2019
  • Chapman DG, Irvin CG, Kaminsky DA, et al. Influence of distinct asthma phenotypes on lung function following weight loss in the obese. Respirology. 2014;19(8):1170–1177. doi:10.1111/resp.12368
  • Stolberg CR, Mundbjerg LH, Funch-Jensen P, et al. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis. Surg Obes Relat Dis. 2018;14(7):918–926. doi:10.1016/j.soard.2018.03.022
  • Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res. 1995;3(1):43–48. doi:10.1002/j.1550-8528.1995.tb00119.x
  • Mitchel JA, Antoniak S, Lee J-H, et al. IL-13 augments compressive stress-induced tissue factor expression in human airway epithelial cells. Am J Respir Cell Mol Biol. 2016;54(4):524–531. doi:10.1165/rcmb.2015-0252OC
  • Brims FJ, Chauhan AJ, Higgins B, et al. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Thorax. 2009;64(12):1037–1043. doi:10.1136/thx.2009.114439
  • Shinagawa K, Ploplis VA, Castellino FJ. A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice. Am J Physiol Lung Cell Mol Physiol. 2009;296(5):L763–L770. doi:10.1152/ajplung.90638.2008
  • Ollivier V, Bentolila S, Chabbat J, et al. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998;91(8):2698–2703. doi:10.1182/blood.V91.8.2698.2698_2698_2703
  • Chetta A, Zanini A, Olivieri D. Therapeutic approach to vascular remodelling in asthma. Pulm Pharmacol Ther. 2007;20(1):1–8. doi:10.1016/j.pupt.2005.10.009
  • Walters EH, Reid D, Soltani A, et al. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther. 2008;118(1):128–137. doi:10.1016/j.pharmthera.2008.01.007
  • Walters EH, Soltani A, Reid DW, et al. Vascular remodelling in asthma. Curr Opin Allergy Clin Immunol. 2008;8(1):39–43. doi:10.1097/ACI.0b013e3282f42696
  • Shinagawa K, Martin JA, Ploplis VA, et al. Coagulation factor Xa modulates airway remodeling in a murine model of asthma. Am J Respir Crit Care Med. 2007;175(2):136–143. doi:10.1164/rccm.200608-1097OC
  • Blancbrude OP, Archer F, Leoni P, et al. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res. 2005;304(1):16–27. doi:10.1016/j.yexcr.2004.10.021
  • Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol. 2004;114(5):997–1008; quiz 1009. doi:10.1016/j.jaci.2004.07.060
  • Kornerup KN, Page CP. The role of platelets in the pathophysiology of asthma. Platelets. 2007;18(5):319–328. doi:10.1080/09537100701230436
  • Jennewein C, Tran N, Paulus P, et al. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med. 2011;17(5–6):568–573. doi:10.2119/molmed.2010.00146
  • Levi M, Schultz MJ, Rijneveld AW, et al. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med. 2003;31(4 Suppl):S238–42. doi:10.1097/01.CCM.0000057849.53689.65
  • Robson SC, Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol. 1994;86(2):322–326. doi:10.1111/j.1365-2141.1994.tb04733.x
  • Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–34. doi:10.1097/CCM.0b013e3181c98d21
  • Cho S, Kang J, Lyttle C, et al. Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma. Ann Allergy Asthma Immunol. 2011;106(5):371–377. doi:10.1016/j.anai.2010.12.021
  • Wagers SS, Norton RJ, Rinaldi LM, et al. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest. 2004;114(1):104–111. doi:10.1172/JCI200419569
  • Oh CK, Ariue B, Alban RF, et al. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun. 2002;294(5):1155–1160. doi:10.1016/S0006-291X(02)00577-6
  • Kucharewicz I, Mogielnicki A, Kasacka I, et al. Plasmin system regulation in an ovalbumin-induced rat model of asthma. Int Arch Allergy Immunol. 2008;147(3):190–196. doi:10.1159/000142041
  • Kuramoto E, Nishiuma T, Kobayashi K, et al. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Am J Physiol Lung Cell Mol Physiol. 2009;296(3):L337–L346. doi:10.1152/ajplung.90434.2008
  • Schouten M, Van de pol MA, Levi M, et al. Early activation of coagulation after allergen challenge in patients with allergic asthma. J Thromb Haemost. 2009;7(9):1592–1594. doi:10.1111/j.1538-7836.2009.03523.x
  • Hataji O, Taguchi O, Gabazza EC, et al. Activation of protein C pathway in the airways. Lung. 2002;180(1):47–59. doi:10.1007/s004080000080
  • de Boer JD, Berger M, Majoor CJ, et al. Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial. Eur Respir J. 2015;46(6):1636–1644. doi:10.1183/13993003.00459-2015
  • Yuda H, Adachi Y, Taguchi O, et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood. 2004;103(6):2196–2204. doi:10.1182/blood-2003-06-1980
  • Matsumoto T, Matsushima Y, Toda M, et al. Activated protein C modulates the proinflammatory activity of dendritic cells. J Asthma Allergy. 2015;8:29–37.
  • Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615–621. doi:10.1111/j.1538-7836.2012.04653.x
  • Carmeliet P, Mackman N, Moons L, et al. Role of tissue factor in embryonic blood vessel development. Nature. 1996;383(6595):73–75. doi:10.1038/383073a0
  • Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24(6):1015–1022. doi:10.1161/01.ATV.0000130465.23430.74
  • Marin G, Gamez AS, Molinari N, et al. Distal airway impairment in obese normoreactive women. Biomed Res Int. 2013;2013:707856. doi:10.1155/2013/707856
  • Guidelines (2013) for managing overweight and obesity in adults. Preface to the Expert Panel Report (comprehensive version which includes systematic evidence review, evidence statements, and recommendations). Obesity (Silver Spring). 2014;22 Suppl 2:S40.
  • Bullo M, García-Lorda P, Megias I, et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003;11(4):525–531. doi:10.1038/oby.2003.74
  • Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013;2013:139239. doi:10.1155/2013/139239
  • Molofsky AB, Nussbaum JC, Liang H-E, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med. 2013;210(3):535–549. doi:10.1084/jem.20121964
  • Miethe S, Karsonova A, Karaulov A, et al. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685–693. doi:10.1016/j.jaci.2020.08.011
  • Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013;122(20):3415–3422. doi:10.1182/blood-2013-05-427708
  • Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9(1):88. doi:10.1186/1471-2458-9-88
  • Vilahur G, Ben-Aicha S, Badimon L. New insights into the role of adipose tissue in thrombosis. Cardiovasc Res. 2017;113(9):1046–1054. doi:10.1093/cvr/cvx086
  • Samad F, Pandey M, Loskutoff DJ. Regulation of tissue factor gene expression in obesity. Blood. 2001;98(12):3353–3358. doi:10.1182/blood.V98.12.3353
  • Eriksson P, Reynisdottir S, Lönnqvist F, et al. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41(1):65–71. doi:10.1007/s001250050868
  • Batist G, Bothe A, Bern M, et al. Low antithrombin III in morbid obesity: return to normal with weight reduction. JPEN J Parenter Enteral Nutr. 1983;7(5):447–449. doi:10.1177/0148607183007005447
  • Sola E, Navarro S, Medina P, et al. Activated protein C levels in obesity and weight loss influence. Thromb Res. 2009;123(5):697–700. doi:10.1016/j.thromres.2008.07.017
  • Ay L, Kopp H-P, Brix J-M, et al. Thrombin generation in morbid obesity: significant reduction after weight loss. J Thromb Haemost. 2010;8(4):759–765. doi:10.1111/j.1538-7836.2010.03766.x
  • Rega-Kaun G, Kaun C, Ebenbauer B, et al. Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin. J Thromb Thrombolysis. 2019;47(1):51–56. doi:10.1007/s11239-018-1744-9
  • Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev. 2002;3(2):85–101. doi:10.1046/j.1467-789X.2002.00056.x
  • Heinz S, Braspenning J. Measurement of blood coagulation factor synthesis in cultures of human hepatocytes. Methods Mol Biol. 2015;1250:309–316.
  • Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev. 2009;10(5):554–563. doi:10.1111/j.1467-789X.2009.00593.x
  • Takahashi N, Yoshizaki T, Hiranaka N, et al. The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol. Int J Obes (Lond). 2015;39(5):747–754. doi:10.1038/ijo.2014.208
  • Rafail S, Ritis K, Schaefer K, et al. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFalpha involvement. Thromb Res. 2008;122(3):366–375. doi:10.1016/j.thromres.2007.12.018
  • Singh P, Peterson TE, Barber KR, et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochem Biophys Res Commun. 2010;392(1):47–52. doi:10.1016/j.bbrc.2009.12.158
  • Hao W, Wang J, Zhang Y, et al. Leptin positively regulates MUC5AC production and secretion induced by interleukin-13 in human bronchial epithelial cells. Biochem Biophys Res Commun. 2017;493(2):979–984. doi:10.1016/j.bbrc.2017.09.106
  • Watanabe K, Suzukawa M, Arakawa S, et al. Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor. Allergol Int. 2019;68:S3–S8. doi:10.1016/j.alit.2019.04.002
  • Kato H, Ueki S, Kamada R, et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int Arch Allergy Immunol. 2011;155(4):335–344. doi:10.1159/000321195
  • Dellas C, Schäfer K, Rohm I, et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost. 2008;100(12):1123–1129. doi:10.1160/TH08-05-0314
  • Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001;104(25):3052–3056. doi:10.1161/hc5001.101061
  • Bester J, Pretorius E. Effects of IL-1beta, IL-6 and IL-8 on erythrocytes platelets and clot viscoelasticity. Sci Rep. 2016;6:32188.
  • Muc M, Todo-Bom A, Mota-Pinto A, et al. Leptin and resistin in overweight patients with and without asthma. Allergol Immunopathol (Madr). 2014;42(5):415–421. doi:10.1016/j.aller.2013.03.004
  • Ayer JG, Song C, Steinbeck K, et al. Increased tissue factor activity in monocytes from obese young adults. Clin Exp Pharmacol Physiol. 2010;37(11):1049–1054. doi:10.1111/j.1440-1681.2010.05430.x
  • Calabro P, Cirillo P, Limongelli G, et al. Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-ĸB-dependent pathway. J Vasc Res. 2011;48(1):59–66. doi:10.1159/000318775
  • Ikeda Y, Tsuchiya H, Hama S, et al. Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2014;448(2):129–133. doi:10.1016/j.bbrc.2014.03.076
  • Kato H, Kashiwagi H, Shiraga M, et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol. 2006;26(1):224–230. doi:10.1161/01.ATV.0000194076.84568.81
  • Elbatarny HS, Netherton SJ, Ovens JD, et al. Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases. Eur J Pharmacol. 2007;558(1–3):7–13. doi:10.1016/j.ejphar.2006.11.052
  • Okamoto Y, Ishii S, Croce K, et al. Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. Atherosclerosis. 2013;226(2):373–377. doi:10.1016/j.atherosclerosis.2012.12.012
  • Forrester DL, Britton J, Lewis SA, et al. Impact of adopting low sodium diet on biomarkers of inflammation and coagulation: a randomised controlled trial. J Nephrol. 2010;23(1):49–54.
  • Liang G, Huang X, Hirsch J, et al. Modest gains after an 8-week exercise program correlate with reductions in non-traditional markers of cardiovascular risk. Front Cardiovasc Med. 2021;8:669110. doi:10.3389/fcvm.2021.669110
  • Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508e1-2–515e1-2. doi:10.1016/j.jaci.2011.06.009
  • Guerron AD, Ortega CB, Lee H-J, et al. Asthma medication usage is significantly reduced following bariatric surgery. Surg Endosc. 2019;33(6):1967–1975. doi:10.1007/s00464-018-6500-x
  • Pelosi P, Croci M, Ravagnan I, et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg. 1998;87(3):654–660.
  • Hedenstierna G, Santesson J. Breathing mechanics, dead space and gas exchange in the extremely obese, breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation. Acta Anaesthesiol Scand. 1976;20(3):248–254. doi:10.1111/j.1399-6576.1976.tb05036.x
  • Sharp JT, Henry JP, Sweany SK, et al. The total work of breathing in normal and obese men. J Clin Invest. 1964;43(4):728–739. doi:10.1172/JCI104957
  • Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755–767. doi:10.1080/17476348.2018.1506331
  • Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol. 2005;25(10):2216–2221. doi:10.1161/01.ATV.0000183718.62409.ea
  • Yadav R, Hama S, Liu Y, et al. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes. Front Immunol. 2017;8:1512. doi:10.3389/fimmu.2017.01512
  • Shih K-C, Janckila AJ, Lee W-J, et al. Effects of bariatric weight loss surgery on glucose metabolism, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese adults. Clin Chim Acta. 2016;453:197–202. doi:10.1016/j.cca.2015.11.004
  • Netto BDM, Bettini SC, Clemente APG, et al. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–1018. doi:10.1007/s11695-014-1484-7
  • van Huisstede A, Rudolphus A, Castro Cabezas M, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax. 2015;70(7):659–667. doi:10.1136/thoraxjnl-2014-206712
  • Cugno M, Castelli R, Mari D, et al. Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding. Intern Emerg Med. 2012;7(3):237–242. doi:10.1007/s11739-011-0522-x
  • Pedersen NB, Stolberg CR, Mundbjerg LH, et al. Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery. Clin Obes. 2020;10(6):e12397. doi:10.1111/cob.12397
  • Nestvold TK, Nielsen EW, Ludviksen JK, et al. Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4. Metab Syndr Relat Disord. 2015;13(1):29–35. doi:10.1089/met.2014.0099
  • Hempen M, Kopp H-P, Elhenicky M, et al. YKL-40 is elevated in morbidly obese patients and declines after weight loss. Obes Surg. 2009;19(11):1557–1563. doi:10.1007/s11695-009-9917-4
  • Bradding P, Arthur G. Mast cells in asthma–state of the art. Clin Exp Allergy. 2016;46(2):194–263.
  • Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004;44(1):6–11. doi:10.1161/01.HYP.0000130484.20501.df
  • Pardina E, Ferrer R, Rivero J, et al. Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients. Obesity (Silver Spring). 2012;20(5):1048–1056. doi:10.1038/oby.2011.361
  • Ali MM, Naquiallah D, Qureshi M. et al. DNA methylation profile of genes involved in inflammation and autoimmunity correlates with vascular function in morbidly obese adults. Epigenetics;2021. 1–17. doi:10.1080/15592294.2021.1876285
  • Nicoletti CF, Nonino CB, de Oliveira BAP, et al. DNA methylation and hydroxymethylation levels in relation to two weight loss strategies: energy-restricted diet or bariatric surgery. Obes Surg. 2016;26(3):603–611. doi:10.1007/s11695-015-1802-8
  • Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med. 1997;156(1):229–233. doi:10.1164/ajrccm.156.1.9607066
  • Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax. 2001;56(12):902–906. doi:10.1136/thorax.56.12.902
  • Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581–611.
  • Kanazawa H, Hirata K, Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax. 2002;57(10):885–888. doi:10.1136/thorax.57.10.885
  • Asai K, Kanazawa H, Kamoi H, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33(5):595–599. doi:10.1046/j.1365-2222.2003.01576.x
  • Moreno RH, Hogg JC, Pare PD. Mechanics of airway narrowing. Am Rev Respir Dis. 1986;133(6):1171–1180.
  • Goldie RG, Pedersen KE. Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction. Clin Exp Pharmacol Physiol. 1995;22(6–7):387–396. doi:10.1111/j.1440-1681.1995.tb02028.x
  • Shute JK, Puxeddu E, Calzetta L. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD. Curr Opin Pharmacol. 2018;40:39–45. doi:10.1016/j.coph.2018.01.006
  • Schmid-Grendelmeier P, Altznauer F, Fischer B, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol. 2002;169(2):1021–1027. doi:10.4049/jimmunol.169.2.1021
  • Maggi L, Mazzoni A, Capone M. et al. The dual function of ILC2: from host protection to pathogenic players in type 2 asthma. Mol Aspects Med;2021. 100981. doi:10.1016/j.mam.2021.100981
  • Kwak S, Kim Y-D, Na HG, et al. Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. Biochem Biophys Res Commun. 2018;499(3):655–661. doi:10.1016/j.bbrc.2018.03.206
  • Medoff BD, Okamoto Y, Leyton P, et al. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol. 2009;41(4):397–406. doi:10.1165/rcmb.2008-0415OC
  • Zhu XL, Qin XQ, Xiang Y, et al. Adipokine adiponectin is a potential protector to human bronchial epithelial cell for regulating proliferation, wound repair and apoptosis: comparison with leptin and resistin. Peptides. 2013;40:34–41. doi:10.1016/j.peptides.2012.11.017